As of June 2023 uniQure has a market cap of $0.98 Billion. This makes uniQure the world's 4764th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $0.98 B | -7.64% |
2022 | $1.06 B | 10.73% |
2021 | $0.95 B | -40.38% |
2020 | $1.60 B | -48.68% |
2019 | $3.13 B | 190.99% |
2018 | $1.07 B | 78.41% |
2017 | $0.60 B | 328.64% |
2016 | $0.14 B | -65.02% |
2015 | $0.40 B | 50.23% |
2014 | $0.26 B |
On Jun 1st, 2023 the market cap of uniQure was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | $114.49 B | 11,579.93% | ๐บ๐ธ USA |
![]() Sanofi SNY | $126.03 B | 12,757.84% | ๐ซ๐ท France |
![]() Sangamo Therapeutics
SGMO | $0.19 B | -80.54% | ๐บ๐ธ USA |
![]() bluebird bio
BLUE | $0.37 B | -61.57% | ๐บ๐ธ USA |
![]() BioMarin Pharmaceutical BMRN | $16.56 B | 1,590.06% | ๐บ๐ธ USA |
![]() Avidity Biosciences RNA | $0.76 B | -21.47% | ๐บ๐ธ USA |